We are live on ! Find out more
FRA

Front Row Advisors Portfolio holdings

AUM $296M
1-Year Est. Return 34.73%
This Fund
S&P 500
This Quarter Est. Return
+12.75%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
AUM
$218M
AUM Growth
+$661K
Cap. Flow
-$23.6M
Cap. Flow %
-10.83%
Top 10 Hldgs %
42.05%
Holding
929
New
3
Increased
17
Reduced
215
Closed
452

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$1.32M
2
CVX icon
Chevron
CVX
+$1.25M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.2M
4
LLY icon
Eli Lilly
LLY
+$562K
5
JPM icon
JPMorgan Chase
JPM
+$553K

Sector Composition

Rank Sector Weight
1 Technology 46.32%
2 Healthcare 10.53%
3 Consumer Staples 7.26%
4 Industrials 5.97%
5 Financials 5.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TDY icon
401
Teledyne Technologies
TDY
$30.4B
$2.68K ﹤0.01%
6
JAZZ icon
402
Jazz Pharmaceuticals
JAZZ
$15.9B
$2.58K ﹤0.01%
21
-50
-70% -$6.24K
SWKS icon
403
Skyworks Solutions
SWKS
$9.06B
$2.53K ﹤0.01%
22
IPG
404
DELISTED
Interpublic Group of Companies
IPG
$2.48K ﹤0.01%
76
TTWO icon
405
Take-Two Interactive
TTWO
$43B
$2.41K ﹤0.01%
15
-41
-73% -$6.12K
ISTB icon
406
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.08B
$2.38K ﹤0.01%
50
HYG icon
407
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
$2.32K ﹤0.01%
30
-400
-93% -$29.8K
FOR icon
408
Forestar Group
FOR
$1.44B
$2.31K ﹤0.01%
70
GS icon
409
Goldman Sachs
GS
$313B
$2.31K ﹤0.01%
6
-47
-89% -$15.7K
TAK icon
410
Takeda Pharmaceutical
TAK
$55.1B
$2.07K ﹤0.01%
145
-315
-68% -$4.47K
UAL icon
411
United Airlines
UAL
$38.4B
$2.06K ﹤0.01%
50
FENI icon
412
Fidelity Enhanced International ETF
FENI
$10.4B
$2.01K ﹤0.01%
+76
New +$1.95K
LNTH icon
413
Lantheus
LNTH
$6.82B
$1.92K ﹤0.01%
31
XPH icon
414
State Street SPDR S&P Pharmaceuticals ETF
XPH
$469M
$1.88K ﹤0.01%
45
XBI icon
415
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$1.79K ﹤0.01%
20
FSR
416
DELISTED
Fisker Inc.
FSR
$1.75K ﹤0.01%
1,000
SLYV icon
417
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$4.89B
$1.67K ﹤0.01%
20
VWOB icon
418
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.15B
$1.59K ﹤0.01%
25
EMLC icon
419
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.74B
$1.57K ﹤0.01%
62
GEHC icon
420
GE HealthCare
GEHC
$27.6B
$1.55K ﹤0.01%
20
-849
-98% -$59.5K
NMM icon
421
Navios Maritime Partners
NMM
$2.25B
$1.54K ﹤0.01%
55
FTEC icon
422
Fidelity MSCI Information Technology Index ETF
FTEC
$19.9B
$1.44K ﹤0.01%
10
HYLB icon
423
Xtrackers USD High Yield Corporate Bond ETF
HYLB
$3.52B
$1.42K ﹤0.01%
40
-93
-70% -$3.19K
FNDB icon
424
Schwab Fundamental US Broad Market Index ETF
FNDB
$1.4B
$1.34K ﹤0.01%
66
QUAL icon
425
iShares MSCI USA Quality Factor ETF
QUAL
$45.8B
$1.32K ﹤0.01%
9

Similar funds

Front Row Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, Front Row Advisors held 929 positions worth $218M, up 0.3% from $217M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Front Row Advisors withdrew a net $23.6M in Q4 2023, closing 452 positions and reducing 215 holdings. Its most notable exit was Vanguard Information Technology ETF, an estimated $416K position sold in full.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 41% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, Front Row Advisors opened a new position in GitLab worth $12.6K.

  • Front Row Advisors's largest Q4 2023 buy was GitLab: 200 shares worth $12.6K.
  • Front Row Advisors added most to Pacer US Cash Cows 100 ETF in Q4 2023, an estimated $30.8K increase.
  • Front Row Advisors's biggest Q4 2023 reduction was ExxonMobil, cutting an estimated $1.32M.
  • Front Row Advisors fully exited Vanguard Information Technology ETF in Q4 2023, selling an estimated $416K.
  • Front Row Advisors's ten largest holdings make up 42% of its $218M portfolio in Q4 2023.
  • Front Row Advisors opened 3 new positions and closed 452 in Q4 2023.
  • Front Row Advisors's portfolio value rose 0.3% quarter-over-quarter to $218M.

Based on Front Row Advisors's 13F filing for Q4 2023, filed 15 Feb 2024.